ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Interim Results Show Vaccine Lowers Breast Cancer Recurrence

December 30, 2011

Elizabeth Miller Will Be Named to Cancer Panel

June 17, 1977

Investigators Present Latest Data On Immunologic Control of Tumors

June 1, 1975

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

NCI Pushes For Hop Concept Review In October; CHOPs Seek Institutions To Volunteer As Evaluations Controls

September 18, 1981

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997